An updated systematic review and meta-analysis of the predictive validity of the general anxiety disorder (GAD)-7 and GAD-2 in screening for anxiety disorders
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.119913 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Seong-Hi Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Soonchunhyang University, Asan, Republic of Korea. Electronic address: shpark2015@sch.ac.kr. Hauptthemen laut MEDLINE: Anxiety Disorders, Psychiatric Status Rating Scales. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Soonchunhyang University.
Abstract (Originalsprache)
BACKGROUND: This study was an updated systematic review and meta-analysis to examine the validity of the general anxiety disorder (GAD)-7 and GAD-2 for GAD and other anxiety disorders. METHODS: Electronic searches were performed using MEDLINE, EMBASE, CINAHL, and PsycArticles databases. This review compared the predictive validity of the GAD-7, GAD-2, and other anxiety screening tools and conducted a subgroup analysis based on the GAD-7 according to the target anxiety and participant characteristics. RESULTS: In total, 45 studies were selected based on the inclusion criteria. The sensitivity of GAD-7 (43 studies) was 0.81 (95 % CI, 0.78-0.84), specificity was 0.78 (95 % CI, 0.74-0.81), and sROC AUC was 0.87. For GAD-2 (13 studies), the sensitivity was 0.78 (95 % CI, 0.73-0.83), specificity was 0.81 (95 % CI, 0.73-0.86), and sROC AUC was 0.86. For other anxiety screening tools (seven studies) the sensitivity was 0.78 (95 % CI, 0.74-0.82), specificity was 0.81 (95 % CI, 0.74-0.86), sROC AUC was 0.86. In the subgroup analysis according to anxiety targets, when measuring GAD alone, the sensitivity and specificity of GAD-7 were higher than those of other anxiety disorders, with an sROC AUC of 0.88 versus 0.84. In the subgroup analysis of the participants, the sensitivity in patients with epilepsy was 0.89, which was higher than that in other participants. CONCLUSIONS: This study demonstrated that the GAD-7 had adequate diagnostic accuracy, suggesting that it can help screen patients with anxiety disorders. Moreover, the GAD-7 has a high screening validity for anxiety in patients with epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Soonchunhyang University, Asan, Republic of Korea. Electronic address: shpark2015@sch.ac.kr.
- Quality Improvement Team, Soonchunhyang University Hospital Bucheon, Bucheon, Republic of Korea.
Förderung
- Soonchunhyang University
Zitieren
APA
Park, S. H., & Park, S. K. (2025). An updated systematic review and meta-analysis of the predictive validity of the general anxiety disorder (GAD)-7 and GAD-2 in screening for anxiety disorders. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.119913
Vancouver
Park SH, Park SK. An updated systematic review and meta-analysis of the predictive validity of the general anxiety disorder (GAD)-7 and GAD-2 in screening for anxiety disorders. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.119913
BibTeX
@article{Park2025,
author = {Park, Seong-Hi and Park, Sun Kyung},
title = {An updated systematic review and meta-analysis of the predictive validity of the general anxiety disorder (GAD)-7 and GAD-2 in screening for anxiety disorders},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.119913}
}
EUVIMED